Introduction to Human VTCN1/B7-H4 HEK293T Stable Cell Line
Human VTCN1/B7-H4 HEK293T Stable Cell Line is a valuable tool for studying the structure, activity, and potential therapeutic applications of the VTCN1/B7-H4 protein. This stable cell line is derived from HEK293T cells, a human embryonic kidney cell line commonly used in biomedical research. The stable expression of VTCN1/B7-H4 in these cells allows for consistent and reliable production of the protein, making it an ideal model for studying its role in various biological processes.
Structure of VTCN1/B7-H4 Protein
VTCN1/B7-H4 is a member of the B7 family of proteins, which are important regulators of immune responses. It is a type I transmembrane protein, meaning it spans the cell membrane with one end inside the cell and the other outside. The extracellular portion of VTCN1/B7-H4 contains an immunoglobulin (Ig)-like domain, which is involved in protein-protein interactions. This domain is followed by a transmembrane domain and a short cytoplasmic tail.
Activity of VTCN1/B7-H4 Protein
The exact function of VTCN1/B7-H4 is still being elucidated, but it is known to play a role in regulating immune responses. It is expressed on the surface of various immune cells, including T cells, B cells, and natural killer cells. VTCN1/B7-H4 has been shown to inhibit T cell activation and proliferation, suggesting a potential role in immune tolerance. It may also have a role in regulating the balance between pro-inflammatory and anti-inflammatory responses.
In addition to its role in the immune system, VTCN1/B7-H4 has also been implicated in cancer. It is overexpressed in many types of cancer, including breast, ovarian, and lung cancer. Studies have shown that VTCN1/B7-H4 can promote tumor growth and metastasis by inhibiting immune responses and promoting angiogenesis. Therefore, targeting VTCN1/B7-H4 may have therapeutic potential for cancer treatment.
Application of Human VTCN1/B7-H4 HEK293T Stable Cell Line
The Human VTCN1/B7-H4 HEK293T Stable Cell Line is a valuable tool for studying the structure and function of VTCN1/B7-H4 protein. It can be used to investigate the mechanisms of VTCN1/B7-H4-mediated immune regulation and its potential role in cancer development and progression. The stable expression of VTCN1/B7-H4 in HEK293T cells allows for consistent and reproducible production of the protein, making it ideal for use in various assays and experiments.
One of the main applications of this stable cell line is flow cytometry. Flow cytometry is a technique used to analyze and quantify cells based on their physical and chemical characteristics. With the Human VTCN1/B7-H4 HEK293T Stable Cell Line, researchers can perform flow cytometry analysis to study the expression of VTCN1/B7-H4 on different cell types and under different conditions. This can provide valuable insights into the role of VTCN1/B7-H4 in immune regulation and cancer biology.
Furthermore, the Human VTCN1/B7-H4 HEK293T Stable Cell Line can be used as a model for testing potential VTCN1/B7-H4-targeted therapies. By manipulating the expression of VTCN1/B7-H4 in these cells, researchers can evaluate the effects of different compounds on its activity and potentially identify novel therapeutic targets for cancer treatment.
There are no reviews yet.